Article Details
Retrieved on: 2022-12-14 16:39:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biopharma company expects that the “formation of Nexcella is expected to have a minimal impact on Immix Biopharma's financial position, as ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here